85 related articles for article (PubMed ID: 1515880)
21. High-dose carmustine, etoposide and melphalan ('BEM') with autologous stem cell transplantation: a dose-toxicity study.
Ager S; Mahendra P; Richards EM; Bass G; Baglin TP; Marcus RE
Bone Marrow Transplant; 1996 Mar; 17(3):335-40. PubMed ID: 8704683
[TBL] [Abstract][Full Text] [Related]
22. Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue.
Lu C; Braine HG; Kaizer H; Saral R; Tutschka PJ; Santos GW
Cancer Treat Rep; 1984 May; 68(5):711-7. PubMed ID: 6373004
[TBL] [Abstract][Full Text] [Related]
23. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
24. A novel high-dose chemotherapy protocol with autologous hematopoietic rescue in patients with metastatic breast cancer or recurrent non-Hodgkin's lymphoma.
Fontelonga A; Kelly AJ; MacKintosh FR; Hall S; Monroe P; Wilson GS; Shaft D; Ruthven A; Ascensao JL
Bone Marrow Transplant; 1997 May; 19(10):983-8. PubMed ID: 9169642
[TBL] [Abstract][Full Text] [Related]
25. High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term results.
Baker WJ; Vukelja SJ; Burrell LM; Lee N; Perry JJ
Bone Marrow Transplant; 1998 Apr; 21(8):775-8. PubMed ID: 9603400
[TBL] [Abstract][Full Text] [Related]
26. Tandem high-dose chemotherapy with ifosfamide, carboplatin, and teniposide with autologous bone marrow transplantation for the treatment of poor prognosis common epithelial ovarian carcinoma.
Lotz JP; Bouleuc C; André T; Touboul E; Macovei C; Hannoun L; Lefranc JP; Houry S; Uzan S; Izrael V
Cancer; 1996 Jun; 77(12):2550-9. PubMed ID: 8640705
[TBL] [Abstract][Full Text] [Related]
27. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W
Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474
[TBL] [Abstract][Full Text] [Related]
28. Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.
Broun ER; Nichols CR; Mandanas R; Salzman D; Turns M; Hromas R; Cornetta K; Einhorn LH
Bone Marrow Transplant; 1995 Sep; 16(3):353-8. PubMed ID: 8535306
[TBL] [Abstract][Full Text] [Related]
29. Treatment of relapsed and refractory Hodgkin's disease with high dose chemotherapy and autologous bone marrow transplantation.
Brice P; Gisselbrecht C; Ferme C; Lepage E; Baruchel A; Marolleau JP; Gerota O; Boiron M
Nouv Rev Fr Hematol (1978); 1991; 33(3):267-72. PubMed ID: 1956765
[TBL] [Abstract][Full Text] [Related]
30. A study of thiotepa, etoposide and fractionated total body irradiation as a preparative regimen prior to bone marrow transplantation for poor prognosis patients with neuroblastoma.
Kamani N; August CS; Bunin N; Leahey A; Bayever E; Goldwein J; Zusman J; Evans AE; Angio GD
Bone Marrow Transplant; 1996 Jun; 17(6):911-6. PubMed ID: 8807093
[TBL] [Abstract][Full Text] [Related]
31. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer.
Wilczynski SW; Erasmus JJ; Petros WP; Vredenburgh JJ; Folz RJ
Am J Respir Crit Care Med; 1998 Feb; 157(2):565-73. PubMed ID: 9476874
[TBL] [Abstract][Full Text] [Related]
32. Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation.
Todd NW; Peters WP; Ost AH; Roggli VL; Piantadosi CA
Am Rev Respir Dis; 1993 May; 147(5):1264-70. PubMed ID: 8484641
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary drug toxicity following high-dose chemotherapy with autologous bone marrow transplantation: CT findings in 20 cases.
Patz EF; Peters WP; Goodman PC
J Thorac Imaging; 1994; 9(2):129-34. PubMed ID: 8207780
[TBL] [Abstract][Full Text] [Related]
34. Interferon-gamma for delayed pulmonary toxicity syndrome resistant to steroids.
Suratt BT; Lynch DA; Cool CD; Jones RB; Brown KK
Bone Marrow Transplant; 2003 May; 31(10):939-41. PubMed ID: 12748674
[TBL] [Abstract][Full Text] [Related]
35. High-dose chemotherapy regimens for solid tumors.
van der Wall E; Beijnen JH; Rodenhuis S
Cancer Treat Rev; 1995 Mar; 21(2):105-32. PubMed ID: 7758003
[TBL] [Abstract][Full Text] [Related]
36. [Nitrosourea-induced lung diseases].
Massin F; Coudert B; Foucher P; Lombard JN; Reybet-Degat O; Jeannin L; Camus P
Rev Mal Respir; 1992; 9(6):575-82. PubMed ID: 1470749
[TBL] [Abstract][Full Text] [Related]
37. Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation.
Parish JM; Muhm JR; Leslie KO
Mayo Clin Proc; 2003 May; 78(5):630-4. PubMed ID: 12744552
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapy-induced interstitial pneumonitis during treatment of small cell anaplastic lung cancer.
Zimmerman MS; Ruckdeschel JC; Hussain M
J Clin Oncol; 1984 May; 2(5):396-405. PubMed ID: 6726294
[TBL] [Abstract][Full Text] [Related]
39. High dose chemotherapy with autologous marrow rescue in the treatment of resistant solid tumors.
LeMaistre CF; Knight WA
Invest New Drugs; 1983; 1(4):321-9. PubMed ID: 6088420
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy-induced pulmonary toxicity in mice bearing L1210 leukemia.
Cohen MH; Matthews MJ
Oncology; 1983; 40(2):132-7. PubMed ID: 6402746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]